LISINOPRIL

LISINOPRIL was reported 307288 times

LISINOPRIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTESTINAL ANGIOEDEMA 269 0.5604
1 LUPUS VULGARIS 556 0.4413
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 267 0.3997
3 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 206 0.3672
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 386 0.3635
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 684 0.3415
6 NEUROLOGIC NEGLECT SYNDROME 181 0.3255
7 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 654 0.3153
8 C-REACTIVE PROTEIN 277 0.2988
9 SWOLLEN JOINT COUNT INCREASED 945 0.2961
10 NEPHROGENIC ANAEMIA 1334 0.2877
11 DISLOCATION OF VERTEBRA 647 0.2834
12 X-RAY ABNORMAL 495 0.2765
13 HYPERPARATHYROIDISM SECONDARY 682 0.2719
14 RHEUMATIC FEVER 1164 0.2609
15 RETINITIS 428 0.2475
16 REBOUND ACID HYPERSECRETION 729 0.2408
17 CAROTID ARTERY THROMBOSIS 203 0.2391
18 RHEUMATOID FACTOR POSITIVE 1253 0.2167
19 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1448 0.2019
20 FACET JOINT SYNDROME 652 0.2001
21 DUODENAL ULCER PERFORATION 1452 0.1951
22 PERIPHERAL VENOUS DISEASE 757 0.1852
23 ESSENTIAL HYPERTENSION 292 0.1594
24 ADJUSTMENT DISORDER 205 0.1577
25 END STAGE RENAL DISEASE 2831 0.1551
26 ANGIONEUROTIC OEDEMA 413 0.1548
27 ANGIOEDEMA 6729 0.1520
28 PORPHYRIA ACUTE 218 0.1519
29 BRASH SYNDROME 211 0.1503
30 HELICOBACTER INFECTION 1493 0.1451
31 MUSCLE INJURY 1113 0.1342
32 PEMPHIGUS 1667 0.1332
33 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 809 0.1244
34 C-REACTIVE PROTEIN ABNORMAL 791 0.1232
35 CHRONIC KIDNEY DISEASE 9132 0.1201
36 BONE EROSION 423 0.1195
37 FOLLICULITIS 1224 0.1166
38 HAND DEFORMITY 1494 0.1138
39 HYPERCHOLESTEROLAEMIA 1051 0.1087
40 LIP DRY 911 0.1002
41 HAEMORRHAGIC ANAEMIA 436 0.0991
42 DIABETIC NEUROPATHY 482 0.0973
43 PERICARDITIS 1628 0.0968
44 BREAST CANCER STAGE III 625 0.0964
45 ISCHAEMIC CARDIOMYOPATHY 293 0.0955
46 JOINT RANGE OF MOTION DECREASED 1240 0.0924
47 DRUG TOLERANCE DECREASED 256 0.0911
48 WOUND INFECTION 997 0.0910
49 GRIP STRENGTH DECREASED 801 0.0909
50 BURSITIS 1102 0.0907
51 TYPE 2 DIABETES MELLITUS 2946 0.0874
52 EXOSTOSIS 786 0.0860
53 RECALLED PRODUCT ADMINISTERED 820 0.0859
54 RENAL INJURY 2543 0.0855
55 SYNOVITIS 1534 0.0850
56 GLOSSODYNIA 1897 0.0846
57 PERSONALITY DISORDER 221 0.0843
58 GASTROINTESTINAL HYPOMOTILITY 188 0.0833
59 DISTRIBUTIVE SHOCK 187 0.0825
60 AUTOIMMUNE DISORDER 790 0.0810
61 HYPOVOLAEMIA 455 0.0777
62 HAIR DISORDER 637 0.0772
63 WALKING AID USER 509 0.0771
64 FIBROMYALGIA 1861 0.0765
65 PSYCHOLOGICAL TRAUMA 658 0.0762
66 OBESITY 1151 0.0722
67 ULCER HAEMORRHAGE 485 0.0716
68 HYPERKALAEMIA 2462 0.0701
69 SCIATICA 1119 0.0701
70 CORONARY ARTERY DISEASE 2105 0.0694
71 LIVER INJURY 1685 0.0686
72 IRRITABLE BOWEL SYNDROME 1471 0.0685
73 RENAL FAILURE CHRONIC 527 0.0685
74 PUSTULAR PSORIASIS 235 0.0684
75 THERAPEUTIC AGENT TOXICITY 228 0.0683
76 WOUND 1911 0.0683
77 HAIR COLOUR CHANGES 837 0.0672
78 BLOOD CHOLESTEROL INCREASED 3101 0.0665
79 HYPERLIPIDAEMIA 783 0.0655
80 RENAL TUBULAR NECROSIS 642 0.0654
81 ARTERIAL OCCLUSIVE DISEASE 514 0.0653
82 SUSPECTED SUICIDE 302 0.0644
83 RENAL FAILURE ACUTE 2688 0.0633
84 ACUTE KIDNEY INJURY 9626 0.0628
85 LEFT VENTRICULAR HYPERTROPHY 268 0.0626
86 SWOLLEN TONGUE 1922 0.0615
87 CORONARY ARTERIAL STENT INSERTION 311 0.0613
88 BLEPHAROSPASM 385 0.0611
89 LIVE BIRTH 508 0.0607
90 GANGRENE 365 0.0605
91 IMPAIRED GASTRIC EMPTYING 822 0.0602
92 RASH VESICULAR 290 0.0599
93 NON-CARDIAC CHEST PAIN 188 0.0594
94 ECONOMIC PROBLEM 888 0.0585
95 LOWER GASTROINTESTINAL HAEMORRHAGE 433 0.0585
96 ANGINA UNSTABLE 379 0.0583
97 OSTEOARTHRITIS 2465 0.0581
98 CAROTID ARTERY STENOSIS 203 0.0581
99 BLOOD PRESSURE INADEQUATELY CONTROLLED 349 0.0580
100 ATRIOVENTRICULAR BLOCK FIRST DEGREE 251 0.0578
101 PERIPHERAL VASCULAR DISORDER 298 0.0578
102 PROSTATOMEGALY 227 0.0577
103 DIASTOLIC DYSFUNCTION 178 0.0576
104 RENAL FAILURE 7646 0.0575
105 HAIR TEXTURE ABNORMAL 769 0.0574
106 CORONARY ARTERY OCCLUSION 787 0.0573
107 CARDIAC FAILURE CONGESTIVE 4523 0.0563
108 MATERNAL EXPOSURE TIMING UNSPECIFIED 210 0.0559
109 SPINAL OSTEOARTHRITIS 490 0.0557
110 DIVERTICULUM 386 0.0543
111 TUBULOINTERSTITIAL NEPHRITIS 1010 0.0538
112 PRESCRIBED OVERDOSE 1039 0.0536
113 IMPAIRED HEALING 1759 0.0535
114 SPINAL COLUMN STENOSIS 253 0.0535
115 LOWER LIMB FRACTURE 1028 0.0534
116 DIABETIC RETINOPATHY 181 0.0532
117 INTERVERTEBRAL DISC DEGENERATION 492 0.0531
118 ARTERIOSCLEROSIS CORONARY ARTERY 351 0.0529
119 MADAROSIS 613 0.0528
120 MITRAL VALVE INCOMPETENCE 597 0.0527
121 BLOOD POTASSIUM INCREASED 854 0.0525
122 BUNDLE BRANCH BLOCK LEFT 221 0.0521
123 PSORIATIC ARTHROPATHY 2110 0.0519
124 PULMONARY FIBROSIS 996 0.0519
125 PRE-EXISTING CONDITION IMPROVED 323 0.0517
126 BODY HEIGHT DECREASED 552 0.0516
127 SYSTEMIC LUPUS ERYTHEMATOSUS 1810 0.0509
128 SPINAL STENOSIS 210 0.0508
129 UPPER GASTROINTESTINAL HAEMORRHAGE 854 0.0507
130 ACUTE MYOCARDIAL INFARCTION 1494 0.0506
131 NEPHROPATHY 472 0.0505
132 LUPUS-LIKE SYNDROME 457 0.0503
133 ARTERIOSCLEROSIS 474 0.0503
134 CORONARY ARTERY BYPASS 287 0.0499
135 TRICUSPID VALVE INCOMPETENCE 396 0.0498
136 RENAL CYST 394 0.0496
137 RED BLOOD CELL SEDIMENTATION RATE INCREASED 548 0.0495
138 CONTRAINDICATED PRODUCT ADMINISTERED 1479 0.0488
139 SLEEP APNOEA SYNDROME 926 0.0485
140 ANHEDONIA 1272 0.0484
141 FOOT DEFORMITY 536 0.0483
142 AORTIC VALVE INCOMPETENCE 203 0.0477
143 HIP ARTHROPLASTY 728 0.0475
144 LIP SWELLING 1573 0.0472
145 BREAST CANCER STAGE II 386 0.0463
146 GOUT 832 0.0463
147 NIGHT SWEATS 1485 0.0460
148 BLISTER 2578 0.0459
149 ATELECTASIS 443 0.0458
150 MULTIPLE INJURIES 288 0.0457
151 JOINT DISLOCATION 480 0.0454
152 CARDIAC MURMUR 391 0.0451
153 BLOOD UREA INCREASED 749 0.0447
154 ARTHROPATHY 2470 0.0444
155 GASTROOESOPHAGEAL REFLUX DISEASE 3557 0.0441
156 INTESTINAL ISCHAEMIA 243 0.0441
157 BACK DISORDER 717 0.0441
158 NAIL DISORDER 385 0.0440
159 OEDEMA 2383 0.0439
160 MUSCULOSKELETAL PAIN 2277 0.0434
161 MYOCARDIAL ISCHAEMIA 493 0.0433
162 BLOOD MAGNESIUM DECREASED 373 0.0432
163 SINUS CONGESTION 583 0.0431
164 SENSORY LOSS 347 0.0431
165 CARDIOMEGALY 529 0.0430
166 ATRIAL FLUTTER 342 0.0428
167 INTERNATIONAL NORMALISED RATIO DECREASED 172 0.0424
168 ROTATOR CUFF SYNDROME 544 0.0423
169 AZOTAEMIA 168 0.0420
170 BUNDLE BRANCH BLOCK RIGHT 193 0.0420
171 CORONARY ARTERY STENOSIS 211 0.0419
172 COLITIS ISCHAEMIC 282 0.0418
173 INJURY 2927 0.0416
174 HYPERTENSION 8813 0.0416
175 TASTE DISORDER 843 0.0415
176 BENIGN PROSTATIC HYPERPLASIA 214 0.0414
177 WHEEZING 2457 0.0414
178 KNEE ARTHROPLASTY 866 0.0411
179 BLOOD SODIUM DECREASED 772 0.0409
180 CARDIOMYOPATHY 605 0.0409
181 HIATUS HERNIA 530 0.0409
182 VITAMIN D DEFICIENCY 396 0.0406
183 OSTEOPENIA 614 0.0404
184 HYPERKERATOSIS 222 0.0402
185 DIZZINESS POSTURAL 390 0.0402
186 INCREASED TENDENCY TO BRUISE 369 0.0401
187 BLOOD CHOLESTEROL ABNORMAL 185 0.0400
188 GAIT INABILITY 1328 0.0397
189 GASTROINTESTINAL HAEMORRHAGE 3314 0.0396
190 DIABETES MELLITUS INADEQUATE CONTROL 699 0.0394
191 CARDIAC VALVE DISEASE 225 0.0393
192 MYOSITIS 352 0.0392
193 DISCOMFORT 2390 0.0391
194 MENTAL STATUS CHANGES 1086 0.0391
195 STOMATITIS 2364 0.0389
196 NOCTURIA 473 0.0389
197 STENT PLACEMENT 309 0.0383
198 SINUS DISORDER 753 0.0380
199 RECTAL HAEMORRHAGE 1627 0.0378
200 ACUTE RESPIRATORY FAILURE 725 0.0376
201 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1963 0.0376
202 BLOOD PRESSURE INCREASED 5733 0.0375
203 CONTUSION 3603 0.0374
204 GLUCOSE TOLERANCE IMPAIRED 221 0.0373
205 INTERNATIONAL NORMALISED RATIO INCREASED 1065 0.0373
206 FLUSHING 3797 0.0373
207 HEPATIC ENZYME INCREASED 2537 0.0372
208 HEPATIC CIRRHOSIS 699 0.0372
209 MOBILITY DECREASED 2667 0.0371
210 COAGULOPATHY 615 0.0369
211 HAEMORRHOIDAL HAEMORRHAGE 180 0.0368
212 TYPE 1 DIABETES MELLITUS 222 0.0368
213 COMPLETED SUICIDE 3071 0.0368
214 BLOOD TESTOSTERONE DECREASED 251 0.0367
215 ACUTE CORONARY SYNDROME 303 0.0365
216 HYPOMAGNESAEMIA 509 0.0365
217 LEFT VENTRICULAR DYSFUNCTION 243 0.0362
218 DYSLIPIDAEMIA 184 0.0362
219 PRESCRIBED UNDERDOSE 722 0.0362
220 GLYCOSYLATED HAEMOGLOBIN INCREASED 910 0.0360
221 DEHYDRATION 4805 0.0360
222 HEMIPLEGIA 299 0.0359
223 ROAD TRAFFIC ACCIDENT 1502 0.0359
224 BLOOD URINE PRESENT 681 0.0358
225 ATRIAL FIBRILLATION 3487 0.0358
226 ABNORMAL LOSS OF WEIGHT 244 0.0358
227 TENDERNESS 373 0.0358
228 LOWER RESPIRATORY TRACT INFECTION 1626 0.0357
229 PANCREATITIS 1884 0.0356
230 BLOOD TRIGLYCERIDES INCREASED 627 0.0354
231 DRY MOUTH 2878 0.0354
232 ECCHYMOSIS 243 0.0354
233 IRON DEFICIENCY ANAEMIA 325 0.0352
234 BLOOD PRESSURE ABNORMAL 700 0.0352
235 LACTIC ACIDOSIS 1139 0.0351
236 WEIGHT FLUCTUATION 367 0.0350
237 DYSPEPSIA 3450 0.0350
238 OSTEOPOROSIS 1442 0.0350
239 RESPIRATORY TRACT CONGESTION 553 0.0348
240 JOINT SWELLING 4189 0.0347
241 PANCREATITIS ACUTE 780 0.0347
242 FLANK PAIN 325 0.0346
243 TRANSIENT ISCHAEMIC ATTACK 1167 0.0346
244 ANGINA PECTORIS 990 0.0345
245 GASTRIC ULCER HAEMORRHAGE 191 0.0344
246 SWELLING 3211 0.0343
247 MYOCARDIAL INFARCTION 5973 0.0342
248 BACK INJURY 372 0.0342
249 BLOOD POTASSIUM DECREASED 1028 0.0342
250 ORTHOSTATIC HYPOTENSION 593 0.0340
251 MOTOR DYSFUNCTION 347 0.0340
252 PROSTATIC SPECIFIC ANTIGEN INCREASED 469 0.0340
253 SINUSITIS 3486 0.0340
254 INTERVERTEBRAL DISC PROTRUSION 743 0.0340
255 FAILURE TO THRIVE 176 0.0339
256 HEART RATE IRREGULAR 765 0.0338
257 POLLAKIURIA 1406 0.0337
258 SWELLING FACE 2194 0.0337
259 COORDINATION ABNORMAL 470 0.0337
260 OEDEMA PERIPHERAL 4106 0.0337
261 DELIRIUM 1164 0.0335
262 SKIN HAEMORRHAGE 497 0.0335
263 VENTRICULAR EXTRASYSTOLES 348 0.0335
264 DIABETES MELLITUS 2553 0.0335
265 CHEST PAIN 6172 0.0333
266 SINUS BRADYCARDIA 322 0.0333
267 PHARYNGEAL OEDEMA 511 0.0332
268 DECUBITUS ULCER 270 0.0331
269 CARPAL TUNNEL SYNDROME 463 0.0330
270 HEMIPARESIS 560 0.0330
271 SEASONAL ALLERGY 467 0.0330
272 GLOMERULAR FILTRATION RATE DECREASED 405 0.0329
273 INTERNAL HAEMORRHAGE 376 0.0329
274 HYPOTENSION 6596 0.0328
275 NERVE COMPRESSION 303 0.0328
276 EAR INFECTION 872 0.0327
277 ELECTROCARDIOGRAM ABNORMAL 256 0.0326
278 BLOOD GLUCOSE FLUCTUATION 357 0.0325
279 SUPRAVENTRICULAR TACHYCARDIA 311 0.0325
280 CARDIAC PACEMAKER INSERTION 193 0.0323
281 PERIPHERAL SWELLING 4987 0.0323
282 EJECTION FRACTION DECREASED 501 0.0322
283 AMNESIA 2097 0.0322
284 EAR PAIN 624 0.0321
285 ARTHRITIS 2523 0.0320
286 LACERATION 301 0.0320
287 HAEMATOCRIT DECREASED 634 0.0319
288 GENERAL SYMPTOM 239 0.0319
289 HAEMORRHAGIC STROKE 249 0.0319
290 ANORECTAL DISCOMFORT 169 0.0318
291 FEELING HOT 1949 0.0318
292 BLOOD CREATININE INCREASED 2074 0.0317
293 JOINT STIFFNESS 833 0.0317
294 INFUSION RELATED REACTION 2089 0.0315
295 LARGE INTESTINE POLYP 218 0.0314
296 MUSCULAR WEAKNESS 3573 0.0314
297 ABDOMINAL DISCOMFORT 5267 0.0314
298 POLYURIA 257 0.0314
299 AFFECT LABILITY 302 0.0314
300 HYPOAESTHESIA 4692 0.0313
301 MUSCULOSKELETAL STIFFNESS 2733 0.0312
302 HAEMORRHOIDS 608 0.0311
303 DYSPHONIA 1813 0.0310
304 MUSCLE STRAIN 268 0.0309
305 SLEEP DISORDER 2179 0.0308
306 CONFUSIONAL STATE 4981 0.0308
307 EATING DISORDER 655 0.0307
308 INJECTION SITE NODULE 338 0.0307
309 VENTRICULAR TACHYCARDIA 507 0.0307
310 SMALL INTESTINAL OBSTRUCTION 377 0.0306
311 MUSCLE SPASTICITY 376 0.0306
312 DYSPNOEA EXERTIONAL 1151 0.0305
313 DECREASED INTEREST 180 0.0305
314 DECREASED APPETITE 7086 0.0305
315 CHOLELITHIASIS 1000 0.0305
316 BLOOD GLUCOSE DECREASED 1463 0.0304
317 VITAMIN D DECREASED 260 0.0304
318 MUSCULOSKELETAL DISCOMFORT 522 0.0303
319 HYPOPHAGIA 773 0.0302
320 ATRIOVENTRICULAR BLOCK 233 0.0301
321 MUSCULOSKELETAL CHEST PAIN 466 0.0301
322 URINE OUTPUT DECREASED 263 0.0301
323 ORAL PAIN 669 0.0298
324 LOCAL SWELLING 521 0.0298
325 HYPONATRAEMIA 1677 0.0297
326 THERAPEUTIC PRODUCT EFFECT DECREASED 1333 0.0297
327 DYSARTHRIA 1120 0.0297
328 LUNG DISORDER 1457 0.0297
329 NERVE INJURY 330 0.0296
330 ANKLE FRACTURE 459 0.0296
331 FEAR 797 0.0296
332 BRONCHITIS 2193 0.0296
333 AORTIC ANEURYSM 225 0.0295
334 BLOOD PRESSURE DECREASED 1964 0.0295
335 HAEMODIALYSIS 248 0.0295
336 RETCHING 629 0.0295
337 COUGH 8264 0.0294
338 ACTIVITIES OF DAILY LIVING IMPAIRED 583 0.0294
339 CATARACT 1753 0.0294
340 MENISCUS INJURY 181 0.0294
341 METABOLIC ACIDOSIS 941 0.0294
342 CYSTITIS 937 0.0294
343 RIB FRACTURE 605 0.0294
344 ASTHENIA 11051 0.0294
345 GROIN PAIN 258 0.0293
346 MICTURITION URGENCY 335 0.0293
347 TROPONIN INCREASED 223 0.0293
348 LEUKOCYTOSIS 530 0.0293
349 RALES 170 0.0292
350 POST-TRAUMATIC STRESS DISORDER 196 0.0292
351 EMPHYSEMA 295 0.0292
352 FLUID RETENTION 1487 0.0292
353 DIVERTICULITIS 810 0.0292
354 WEIGHT DECREASED 8156 0.0292
355 CELLULITIS 1472 0.0292
356 VITREOUS FLOATERS 287 0.0292
357 MUSCLE SPASMS 5357 0.0292
358 ALOPECIA 5719 0.0291
359 REFUSAL OF TREATMENT BY PATIENT 190 0.0291
360 SCOLIOSIS 180 0.0290
361 DISABILITY 573 0.0289
362 ERUCTATION 560 0.0289
363 IMPAIRED QUALITY OF LIFE 416 0.0289
364 CEREBROVASCULAR ACCIDENT 4900 0.0289
365 UPPER-AIRWAY COUGH SYNDROME 238 0.0289
366 BLOOD COUNT ABNORMAL 436 0.0287
367 RHEUMATOID ARTHRITIS 3264 0.0287
368 BRADYCARDIA 1523 0.0287
369 PRESYNCOPE 697 0.0286
370 GAIT DISTURBANCE 5483 0.0286
371 MAJOR DEPRESSION 209 0.0286
372 HAEMATURIA 979 0.0286
373 AGEUSIA 713 0.0286
374 SPINAL COMPRESSION FRACTURE 236 0.0285
375 GASTRITIS 751 0.0285
376 DECREASED ACTIVITY 307 0.0284
377 BLOOD GLUCOSE INCREASED 5339 0.0283
378 BLOOD PRESSURE FLUCTUATION 679 0.0283
379 PULMONARY HYPERTENSION 589 0.0282
380 FAECES DISCOLOURED 613 0.0282
381 HOSPICE CARE 279 0.0282
382 DENTAL CARIES 312 0.0282
383 FLATULENCE 1598 0.0282
384 CARDIOGENIC SHOCK 404 0.0281
385 BALANCE DISORDER 2433 0.0281
386 MEMORY IMPAIRMENT 3865 0.0281
387 DROOLING 194 0.0281
388 ABDOMINAL PAIN UPPER 5773 0.0280
389 HOT FLUSH 2112 0.0280
390 FOOT FRACTURE 529 0.0279
391 DYSURIA 1027 0.0279
392 OSTEOMYELITIS 504 0.0278
393 VENTRICULAR FIBRILLATION 309 0.0278
394 FULL BLOOD COUNT DECREASED 560 0.0278
395 DIABETIC KETOACIDOSIS 667 0.0277
396 LYMPHOEDEMA 192 0.0277
397 UNRESPONSIVE TO STIMULI 716 0.0277
398 FALL 9215 0.0277
399 MULTI-ORGAN FAILURE 478 0.0276
400 DEPRESSION 6286 0.0276
401 HEART RATE DECREASED 970 0.0276
402 ERECTILE DYSFUNCTION 709 0.0276
403 LIGAMENT SPRAIN 273 0.0276
404 PROCTALGIA 177 0.0275
405 HYPOGLYCAEMIA 1334 0.0275
406 DIZZINESS 13716 0.0275
407 EPISTAXIS 2056 0.0275
408 SNEEZING 615 0.0274
409 FLUID OVERLOAD 399 0.0274
410 PARAESTHESIA 4310 0.0274
411 URINARY INCONTINENCE 810 0.0273
412 UPPER RESPIRATORY TRACT INFECTION 1262 0.0273
413 TORSADE DE POINTES 214 0.0273
414 RESTLESS LEGS SYNDROME 496 0.0272
415 EXTRASYSTOLES 190 0.0272
416 DUODENAL ULCER 192 0.0272
417 RENAL IMPAIRMENT 2285 0.0272
418 DIARRHOEA 17533 0.0271
419 PULMONARY MASS 404 0.0271
420 MUSCLE ATROPHY 343 0.0270
421 RED BLOOD CELL COUNT DECREASED 774 0.0270
422 LUNG INFILTRATION 239 0.0270
423 WHITE BLOOD CELL COUNT INCREASED 1036 0.0270
424 ARTHROPOD BITE 200 0.0270
425 SKIN ULCER 697 0.0269
426 HEAD INJURY 851 0.0269
427 LOCALISED INFECTION 650 0.0269
428 DRUG INTOLERANCE 2594 0.0268
429 PRURITUS GENERALISED 580 0.0268
430 PAIN IN EXTREMITY 7897 0.0268
431 MALIGNANT MELANOMA 359 0.0268
432 BOWEL MOVEMENT IRREGULARITY 205 0.0267
433 CARDIAC FLUTTER 173 0.0267
434 SHOCK 615 0.0267
435 CONSTIPATION 5830 0.0267
436 INCONTINENCE 282 0.0267
437 MALNUTRITION 298 0.0266
438 CHOLECYSTITIS 317 0.0266
439 CONCUSSION 206 0.0266
440 LABORATORY TEST ABNORMAL 782 0.0265
441 RENAL DISORDER 1232 0.0264
442 ACIDOSIS 202 0.0264
443 POLYP 173 0.0264
444 NECK PAIN 1475 0.0264
445 PULMONARY OEDEMA 1180 0.0263
446 BONE DISORDER 480 0.0263
447 HEPATIC STEATOSIS 489 0.0262
448 BLOOD CALCIUM INCREASED 230 0.0262
449 ATRIOVENTRICULAR BLOCK COMPLETE 175 0.0261
450 JOINT INJURY 558 0.0261
451 INITIAL INSOMNIA 268 0.0261
452 ANXIETY 7396 0.0260
453 SYNCOPE 2598 0.0259
454 IMPAIRED DRIVING ABILITY 294 0.0258
455 MIDDLE INSOMNIA 483 0.0258
456 FATIGUE 20138 0.0258
457 ABASIA 637 0.0258
458 RASH PRURITIC 1395 0.0257
459 CHROMATURIA 581 0.0257
460 BACK PAIN 5974 0.0257
461 FEELING JITTERY 490 0.0257
462 LIPASE INCREASED 197 0.0257
463 LOW DENSITY LIPOPROTEIN INCREASED 199 0.0257
464 HYPERSOMNIA 735 0.0256
465 BASAL CELL CARCINOMA 400 0.0256
466 TOOTH FRACTURE 282 0.0256
467 PHARYNGEAL SWELLING 250 0.0255
468 TOOTH ABSCESS 260 0.0255
469 DYSSTASIA 745 0.0255
470 LIMB INJURY 693 0.0255
471 HYDRONEPHROSIS 191 0.0255
472 DYSPHAGIA 2415 0.0254
473 DYSGEUSIA 1889 0.0254
474 LIVER DISORDER 1124 0.0253
475 ABNORMAL DREAMS 699 0.0253
476 GLAUCOMA 487 0.0253
477 INSOMNIA 6731 0.0252
478 TOOTH INFECTION 333 0.0252
479 BLOOD GLUCOSE ABNORMAL 466 0.0252
480 RHINORRHOEA 1630 0.0252
481 GALLBLADDER DISORDER 450 0.0252
482 BLADDER DISORDER 250 0.0252
483 APHASIA 760 0.0251
484 HYPOKALAEMIA 1161 0.0251
485 NEUROPATHY PERIPHERAL 2390 0.0251
486 URINARY TRACT INFECTION 4284 0.0251
487 BLOOD IRON DECREASED 298 0.0251
488 SUBDURAL HAEMATOMA 359 0.0251
489 ANOREXIA 323 0.0250
490 WEIGHT INCREASED 5590 0.0249
491 DYSPNOEA 14126 0.0249
492 HAEMORRHAGE INTRACRANIAL 373 0.0249
493 HYPERGLYCAEMIA 907 0.0249
494 GINGIVAL PAIN 198 0.0249
495 PROTEINURIA 472 0.0248
496 RESPIRATORY DISTRESS 684 0.0248
497 RENAL PAIN 262 0.0247
498 SPINAL DISORDER 234 0.0247
499 WRIST FRACTURE 296 0.0247
500 PULMONARY THROMBOSIS 269 0.0246
501 STAPHYLOCOCCAL INFECTION 813 0.0246
502 THIRST 440 0.0246
503 HYPOXIA 865 0.0245
504 SKIN LACERATION 267 0.0245
505 NASOPHARYNGITIS 4519 0.0245
506 HERNIA 474 0.0245
507 MULTIPLE ALLERGIES 192 0.0245
508 INFLAMMATION 1263 0.0244
509 THYROID DISORDER 377 0.0244
510 BLOOD CALCIUM DECREASED 275 0.0244
511 UPPER LIMB FRACTURE 487 0.0244
512 NEURALGIA 594 0.0244
513 EYE PAIN 1377 0.0244
514 DRY THROAT 248 0.0244
515 ILL-DEFINED DISORDER 1480 0.0243
516 PRODUCT ADMINISTRATION INTERRUPTED 191 0.0243
517 HAEMOPTYSIS 678 0.0243
518 MACULAR DEGENERATION 290 0.0243
519 EYE HAEMORRHAGE 324 0.0243
520 HAEMATEMESIS 615 0.0242
521 FREQUENT BOWEL MOVEMENTS 655 0.0242
522 ILEUS 301 0.0242
523 GASTROINTESTINAL DISORDER 2166 0.0242
524 SQUAMOUS CELL CARCINOMA 227 0.0241
525 VISUAL FIELD DEFECT 174 0.0241
526 NEPHROLITHIASIS 1104 0.0240
527 GASTRIC ULCER 457 0.0240
528 SINUS TACHYCARDIA 341 0.0240
529 UROSEPSIS 221 0.0239
530 LETHARGY 1378 0.0239
531 RHABDOMYOLYSIS 997 0.0239
532 BIPOLAR DISORDER 259 0.0238
533 VOMITING 11195 0.0238
534 HYPOKINESIA 345 0.0237
535 PULMONARY CONGESTION 313 0.0237
536 OESOPHAGITIS 259 0.0237
537 MYALGIA 4030 0.0237
538 ATAXIA 281 0.0237
539 BURNING SENSATION 1660 0.0236
540 SCAR 405 0.0236
541 NAUSEA 18707 0.0236
542 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 401 0.0236
543 GINGIVAL BLEEDING 322 0.0236
544 PLEURAL EFFUSION 1432 0.0235
545 ANAEMIA 4488 0.0235
546 ARTHRALGIA 9773 0.0235
547 POOR QUALITY SLEEP 506 0.0235
548 HEART RATE INCREASED 2328 0.0235
549 HAEMOGLOBIN DECREASED 2401 0.0234
550 PERIPHERAL COLDNESS 320 0.0233
551 THERAPY NON-RESPONDER 1047 0.0233
552 GASTROENTERITIS VIRAL 420 0.0232
553 VISION BLURRED 3192 0.0232
554 INTENTIONAL PRODUCT USE ISSUE 2033 0.0232
555 PARAESTHESIA ORAL 334 0.0231
556 FEELING DRUNK 172 0.0231
557 HYPERSENSITIVITY 4295 0.0231
558 ULCER 368 0.0231
559 ORAL DISCOMFORT 321 0.0231
560 BLOOD ALBUMIN DECREASED 183 0.0230
561 CHOLECYSTECTOMY 263 0.0230
562 LIMB DISCOMFORT 712 0.0230
563 CYST 285 0.0229
564 TENDON RUPTURE 283 0.0229
565 LOSS OF CONSCIOUSNESS 2929 0.0228
566 SLUGGISHNESS 233 0.0228
567 LACRIMATION INCREASED 690 0.0228
568 PERICARDIAL EFFUSION 528 0.0228
569 NERVOUSNESS 1193 0.0228
570 ABNORMAL FAECES 187 0.0228
571 CARDIAC DISORDER 2133 0.0228
572 DRUG DOSE OMISSION 3764 0.0227
573 PELVIC FRACTURE 177 0.0227
574 BLOOD PRESSURE SYSTOLIC INCREASED 443 0.0227
575 TOOTHACHE 411 0.0227
576 COLD SWEAT 400 0.0227
577 PNEUMONIA 7346 0.0227
578 PSORIASIS 2963 0.0227
579 HYPERHIDROSIS 2920 0.0226
580 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 387 0.0226
581 DEEP VEIN THROMBOSIS 1465 0.0225
582 MASS 315 0.0225
583 GASTRIC DISORDER 771 0.0224
584 ANAL INCONTINENCE 202 0.0224
585 PRODUCTIVE COUGH 1072 0.0224
586 PAIN 13790 0.0224
587 TOOTH DISORDER 499 0.0224
588 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1077 0.0224
589 ABDOMINAL PAIN 5208 0.0224
590 INJECTION SITE EXTRAVASATION 276 0.0223
591 MYOPATHY 193 0.0223
592 POST PROCEDURAL HAEMORRHAGE 260 0.0223
593 GENERAL PHYSICAL HEALTH DETERIORATION 2583 0.0223
594 EAR DISCOMFORT 229 0.0223
595 SCAB 254 0.0222
596 CLOSTRIDIUM DIFFICILE COLITIS 236 0.0222
597 DRUG INTERACTION 3523 0.0222
598 ELECTROLYTE IMBALANCE 258 0.0222
599 DISORIENTATION 872 0.0220
600 DIALYSIS 312 0.0220
601 FURUNCLE 174 0.0219
602 HYPERTENSIVE CRISIS 244 0.0219
603 THERAPY CESSATION 1124 0.0219
604 POST PROCEDURAL COMPLICATION 420 0.0218
605 RESPIRATORY FAILURE 1594 0.0218
606 MUSCLE TIGHTNESS 353 0.0218
607 PALPITATIONS 2549 0.0217
608 HYPOAESTHESIA ORAL 328 0.0217
609 INTENTIONAL PRODUCT MISUSE 1905 0.0217
610 FACIAL PAIN 194 0.0217
611 URINARY RETENTION 725 0.0217
612 CHOKING 423 0.0217
613 GASTROENTERITIS 316 0.0216
614 TREATMENT NONCOMPLIANCE 1184 0.0216
615 WRONG TECHNIQUE IN DRUG USAGE PROCESS 786 0.0216
616 CHEST DISCOMFORT 2215 0.0216
617 BLINDNESS UNILATERAL 305 0.0216
618 MIGRAINE 2064 0.0216
619 FEELING ABNORMAL 5160 0.0215
620 THERAPEUTIC RESPONSE UNEXPECTED 966 0.0215
621 EYE INFECTION 243 0.0215
622 HIP FRACTURE 689 0.0214
623 HAEMATOMA 555 0.0214
624 CARDIAC OPERATION 184 0.0214
625 NODULE 279 0.0214
626 PRODUCT DOSE OMISSION 1394 0.0213
627 HICCUPS 175 0.0213
628 RESPIRATORY DISORDER 637 0.0213
629 OROPHARYNGEAL PAIN 1968 0.0212
630 KIDNEY INFECTION 416 0.0212
631 CARDIAC ARREST 1750 0.0212
632 QUALITY OF LIFE DECREASED 284 0.0211
633 PRURITUS 8126 0.0211
634 TEMPERATURE INTOLERANCE 218 0.0211
635 ASTHMA 2384 0.0211
636 HYPOTHYROIDISM 673 0.0211
637 HEADACHE 13193 0.0210
638 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 216 0.0210
639 URTICARIA 3522 0.0210
640 PHOTOPHOBIA 395 0.0210
641 MUSCLE DISORDER 170 0.0210
642 INCREASED APPETITE 401 0.0210
643 SKIN DISCOLOURATION 964 0.0210
644 RASH GENERALISED 543 0.0209
645 RASH MACULAR 732 0.0209
646 UNEVALUABLE EVENT 1584 0.0209
647 ABDOMINAL DISTENSION 2185 0.0209
648 THINKING ABNORMAL 390 0.0209
649 POST PROCEDURAL INFECTION 170 0.0209
650 TRANSFUSION 219 0.0209
651 PAIN IN JAW 591 0.0208
652 OBSTRUCTIVE AIRWAYS DISORDER 232 0.0208
653 BLOOD TEST ABNORMAL 293 0.0208
654 THROMBOSIS 1677 0.0208
655 SPLENOMEGALY 244 0.0208
656 SPINAL OPERATION 256 0.0208
657 INTENTIONAL DOSE OMISSION 592 0.0207
658 HALLUCINATION, VISUAL 438 0.0207
659 ASPIRATION 227 0.0207
660 SKIN LESION 566 0.0206
661 VISUAL IMPAIRMENT 2550 0.0206
662 INTENTIONAL DRUG MISUSE 430 0.0205
663 VISUAL ACUITY REDUCED 683 0.0205
664 TENDONITIS 318 0.0205
665 SEPSIS 2287 0.0205
666 THROAT TIGHTNESS 553 0.0204
667 SPINAL FRACTURE 409 0.0204
668 SPEECH DISORDER 1069 0.0204
669 PRODUCT QUALITY ISSUE 2755 0.0203
670 PLATELET COUNT INCREASED 264 0.0202
671 TINNITUS 929 0.0202
672 NASAL CONGESTION 1185 0.0201
673 PRODUCT TASTE ABNORMAL 273 0.0201
674 SUBARACHNOID HAEMORRHAGE 205 0.0201
675 TREMOR 3340 0.0201
676 C-REACTIVE PROTEIN INCREASED 732 0.0201
677 THROAT IRRITATION 902 0.0201
678 LIVER FUNCTION TEST ABNORMAL 584 0.0201
679 EYE DISORDER 660 0.0201
680 FEELING COLD 558 0.0200
681 GENERALISED OEDEMA 248 0.0200
682 EYE SWELLING 744 0.0200
683 RASH 8704 0.0199
684 DEMENTIA 558 0.0199
685 OCULAR DISCOMFORT 224 0.0199
686 MELAENA 438 0.0199
687 HALLUCINATION 1493 0.0198
688 DIPLOPIA 514 0.0198
689 PETECHIAE 206 0.0197
690 INFECTION 2856 0.0197
691 PARANOIA 340 0.0197
692 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1402 0.0197
693 TOOTH EXTRACTION 245 0.0197
694 INFLUENZA LIKE ILLNESS 1616 0.0196
695 HYPERCALCAEMIA 242 0.0196
696 CARDIO-RESPIRATORY ARREST 817 0.0195
697 SEROTONIN SYNDROME 374 0.0195
698 SCRATCH 205 0.0194
699 ADVERSE DRUG REACTION 1744 0.0194
700 BLOOD ALKALINE PHOSPHATASE INCREASED 482 0.0194
701 ENCEPHALOPATHY 476 0.0194
702 MALAISE 8490 0.0193
703 KNEE OPERATION 190 0.0193
704 SPUTUM DISCOLOURED 183 0.0193
705 INFLUENZA 2146 0.0192
706 HEPATOMEGALY 189 0.0192
707 PLATELET COUNT DECREASED 2049 0.0192
708 RESPIRATORY RATE INCREASED 170 0.0191
709 CONDITION AGGRAVATED 5822 0.0191
710 RETINAL DETACHMENT 176 0.0191
711 DISEASE RECURRENCE 910 0.0191
712 BONE PAIN 1117 0.0190
713 SECRETION DISCHARGE 238 0.0190
714 SOMNOLENCE 3826 0.0190
715 CHILLS 2220 0.0189
716 ISCHAEMIC STROKE 337 0.0189
717 DRUG EFFECT DECREASED 1016 0.0188
718 DERMATITIS CONTACT 215 0.0188
719 NIGHTMARE 651 0.0188
720 IMPAIRED WORK ABILITY 402 0.0188
721 DELUSION 292 0.0188
722 ARRHYTHMIA 890 0.0188
723 APHONIA 262 0.0188
724 EYE DISCHARGE 195 0.0187
725 EMOTIONAL DISTRESS 2271 0.0187
726 RESPIRATORY ARREST 516 0.0187
727 DEAFNESS 489 0.0187
728 HAEMATOCHEZIA 1030 0.0186
729 HYPOCALCAEMIA 352 0.0186
730 SENSORY DISTURBANCE 298 0.0185
731 MUSCULOSKELETAL DISORDER 353 0.0185
732 RESTLESSNESS 678 0.0185
733 WHITE BLOOD CELL COUNT DECREASED 2008 0.0185
734 MEDICATION ERROR 1019 0.0183
735 VIRAL INFECTION 608 0.0183
736 INTRAOCULAR PRESSURE INCREASED 233 0.0182
737 ORAL CANDIDIASIS 240 0.0182
738 LIVER FUNCTION TEST INCREASED 391 0.0182
739 SKIN DISORDER 607 0.0182
740 FEEDING DISORDER 369 0.0182
741 VERTIGO 1104 0.0181
742 DYSKINESIA 735 0.0181
743 DIARRHOEA HAEMORRHAGIC 169 0.0181
744 CLOSTRIDIUM DIFFICILE INFECTION 394 0.0180
745 HEAD DISCOMFORT 319 0.0180
746 HERPES ZOSTER 1034 0.0180
747 SKIN EXFOLIATION 1515 0.0179
748 MULTIPLE FRACTURES 295 0.0179
749 MENTAL IMPAIRMENT 433 0.0178
750 RASH PAPULAR 400 0.0178
751 FUNGAL INFECTION 594 0.0178
752 PANIC ATTACK 649 0.0178
753 HUNGER 248 0.0178
754 SKIN CANCER 383 0.0178
755 CEREBRAL HAEMORRHAGE 636 0.0177
756 ASCITES 521 0.0177
757 EYE IRRITATION 1017 0.0177
758 PRODUCT SUBSTITUTION ISSUE 1017 0.0176
759 DRUG EFFECT INCOMPLETE 641 0.0176
760 INCORRECT DRUG ADMINISTRATION DURATION 495 0.0176
761 PRODUCT ODOUR ABNORMAL 184 0.0176
762 ADVERSE EVENT 1618 0.0175
763 TREATMENT FAILURE 1453 0.0175
764 COELIAC DISEASE 172 0.0175
765 MUSCLE TWITCHING 404 0.0175
766 INTESTINAL OBSTRUCTION 659 0.0175
767 ANAPHYLACTIC REACTION 963 0.0174
768 IMMUNE SYSTEM DISORDER 229 0.0174
769 SKIN FISSURES 339 0.0173
770 PHARMACEUTICAL PRODUCT COMPLAINT 450 0.0173
771 PRODUCT USE ISSUE 3254 0.0173
772 GASTROINTESTINAL PAIN 190 0.0173
773 TACHYCARDIA 1534 0.0172
774 HYPOACUSIS 742 0.0172
775 BLOOD CREATINE PHOSPHOKINASE INCREASED 494 0.0171
776 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 939 0.0171
777 CARDIAC FAILURE 1372 0.0171
778 PULMONARY EMBOLISM 1624 0.0171
779 PREGNANCY 342 0.0171
780 AGITATION 1252 0.0170
781 BEDRIDDEN 223 0.0169
782 ANGER 572 0.0169
783 BREAST PAIN 180 0.0169
784 DRUG TOXICITY 229 0.0168
785 MOVEMENT DISORDER 539 0.0168
786 RESPIRATORY TRACT INFECTION 436 0.0167
787 COLON CANCER 248 0.0166
788 PRODUCT DOSE OMISSION IN ERROR 470 0.0166
789 INJECTION SITE MASS 613 0.0166
790 OCULAR HYPERAEMIA 784 0.0165
791 OXYGEN SATURATION DECREASED 927 0.0165
792 COLITIS 623 0.0164
793 DISTURBANCE IN ATTENTION 883 0.0164
794 BACTERAEMIA 194 0.0163
795 DRUG-INDUCED LIVER INJURY 512 0.0163
796 DRY EYE 814 0.0163
797 DRUG DISPENSING ERROR 249 0.0163
798 MYOCLONUS 194 0.0163
799 PNEUMONIA ASPIRATION 406 0.0162
800 LUNG INFECTION 252 0.0162
801 BODY TEMPERATURE INCREASED 330 0.0162
802 PNEUMOTHORAX 256 0.0161
803 NO THERAPEUTIC RESPONSE 196 0.0161
804 PYREXIA 5556 0.0160
805 SURGERY 941 0.0160
806 CANDIDA INFECTION 271 0.0160
807 SKIN INFECTION 180 0.0160
808 IMMUNODEFICIENCY 239 0.0160
809 INSURANCE ISSUE 245 0.0160
810 CARDIOVASCULAR DISORDER 404 0.0159
811 ASPARTATE AMINOTRANSFERASE INCREASED 845 0.0159
812 BRAIN FOG 249 0.0159
813 CRYING 577 0.0159
814 LYMPHADENOPATHY 561 0.0158
815 PHARYNGITIS 196 0.0158
816 PRODUCT PHYSICAL ISSUE 318 0.0157
817 RASH ERYTHEMATOUS 753 0.0157
818 DRUG ADMINISTRATION ERROR 482 0.0157
819 COVID-19 PNEUMONIA 185 0.0157
820 HAEMORRHAGE 1637 0.0156
821 FEMUR FRACTURE 484 0.0156
822 EMOTIONAL DISORDER 480 0.0156
823 ABSCESS 248 0.0155
824 COVID-19 2722 0.0155
825 PROCEDURAL PAIN 427 0.0154
826 THERAPEUTIC RESPONSE DECREASED 931 0.0153
827 CONVULSION 877 0.0153
828 PHOTOSENSITIVITY REACTION 253 0.0153
829 MATERNAL EXPOSURE DURING PREGNANCY 1362 0.0153
830 FACE OEDEMA 257 0.0152
831 UNDERDOSE 1107 0.0151
832 EXPIRED PRODUCT ADMINISTERED 503 0.0151
833 DRUG PRESCRIBING ERROR 290 0.0151
834 EYE PRURITUS 507 0.0151
835 THERAPY INTERRUPTED 1069 0.0149
836 BACTERIAL INFECTION 279 0.0149
837 DERMATITIS 313 0.0149
838 WITHDRAWAL SYNDROME 626 0.0149
839 IRRITABILITY 896 0.0149
840 BLINDNESS 606 0.0149
841 TOXICITY TO VARIOUS AGENTS 2507 0.0149
842 ABNORMAL BEHAVIOUR 589 0.0149
843 PRODUCT DOSE OMISSION ISSUE 4351 0.0148
844 CIRCULATORY COLLAPSE 251 0.0147
845 ADRENAL INSUFFICIENCY 178 0.0147
846 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 341 0.0146
847 COGNITIVE DISORDER 683 0.0146
848 TOOTH LOSS 303 0.0146
849 MOOD ALTERED 398 0.0146
850 ANOSMIA 211 0.0146
851 METASTASES TO BONE 239 0.0145
852 MENTAL DISORDER 633 0.0145
853 SEPTIC SHOCK 632 0.0145
854 ALANINE AMINOTRANSFERASE INCREASED 888 0.0144
855 BLOOD BILIRUBIN INCREASED 390 0.0144
856 PANCYTOPENIA 800 0.0143
857 INJECTION SITE HAEMORRHAGE 1142 0.0143
858 MANIA 235 0.0143
859 ERYTHEMA 2927 0.0142
860 DEPRESSED MOOD 747 0.0141
861 TACHYPNOEA 192 0.0141
862 MOOD SWINGS 447 0.0140
863 SUICIDAL IDEATION 1282 0.0140
864 INTENTIONAL OVERDOSE 896 0.0140
865 PLASMA CELL MYELOMA 543 0.0139
866 METASTASES TO LIVER 244 0.0139
867 EPILEPSY 424 0.0139
868 HALLUCINATION, AUDITORY 220 0.0138
869 BONE DENSITY DECREASED 432 0.0138
870 THROMBOCYTOPENIA 1534 0.0137
871 DRUG LEVEL INCREASED 227 0.0137
872 PALLOR 372 0.0137
873 ABDOMINAL PAIN LOWER 345 0.0136
874 HYPERTHYROIDISM 197 0.0136
875 ILLNESS 1397 0.0135
876 DRUG INEFFECTIVE 17857 0.0135
877 ELECTROCARDIOGRAM QT PROLONGED 483 0.0134
878 SARS-COV-2 TEST POSITIVE 176 0.0133
879 INJECTION SITE PRURITUS 886 0.0132
880 PRODUCT USE IN UNAPPROVED INDICATION 3276 0.0132
881 OSTEONECROSIS OF JAW 327 0.0132
882 INJECTION SITE BRUISING 1045 0.0131
883 MOUTH ULCERATION 276 0.0131
884 PRODUCT USE COMPLAINT 205 0.0130
885 ORAL HERPES 254 0.0130
886 INJECTION SITE HAEMATOMA 188 0.0129
887 HEPATIC FAILURE 390 0.0129
888 AGGRESSION 647 0.0129
889 CEREBRAL INFARCTION 315 0.0129
890 APPLICATION SITE PRURITUS 292 0.0129
891 OFF LABEL USE 11262 0.0128
892 DRY SKIN 1715 0.0128
893 DISEASE PROGRESSION 1520 0.0128
894 APPLICATION SITE RASH 175 0.0127
895 APPLICATION SITE PAIN 280 0.0127
896 DEVICE MALFUNCTION 889 0.0126
897 MULTIPLE SCLEROSIS RELAPSE 864 0.0126
898 JAUNDICE 338 0.0125
899 ACUTE RESPIRATORY DISTRESS SYNDROME 220 0.0124
900 PARALYSIS 178 0.0124
901 MULTIPLE SCLEROSIS 594 0.0124
902 INCORRECT DOSE ADMINISTERED 2815 0.0123
903 PSYCHOTIC DISORDER 364 0.0123
904 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 860 0.0121
905 ACCIDENTAL OVERDOSE 442 0.0121
906 EXPOSURE DURING PREGNANCY 745 0.0120
907 PRODUCT AVAILABILITY ISSUE 272 0.0119
908 PSYCHOMOTOR HYPERACTIVITY 198 0.0119
909 PELVIC PAIN 216 0.0119
910 SEIZURE 1369 0.0118
911 APATHY 170 0.0116
912 FRACTURE 220 0.0116
913 INJECTION SITE RASH 356 0.0116
914 DEVICE RELATED INFECTION 178 0.0116
915 NO ADVERSE EVENT 2083 0.0115
916 DEVICE FAILURE 175 0.0115
917 HOSPITALISATION 1761 0.0114
918 INJECTION SITE PAIN 3510 0.0114
919 COLITIS ULCERATIVE 511 0.0114
920 STEVENS-JOHNSON SYNDROME 250 0.0112
921 APPLICATION SITE ERYTHEMA 294 0.0112
922 LYMPHOCYTE COUNT DECREASED 198 0.0112
923 DEPRESSED LEVEL OF CONSCIOUSNESS 441 0.0111
924 TARDIVE DYSKINESIA 311 0.0110
925 NEOPLASM PROGRESSION 378 0.0109
926 PAIN OF SKIN 292 0.0108
927 INJECTION SITE ERYTHEMA 1334 0.0107
928 PRODUCT ADHESION ISSUE 378 0.0106
929 NERVOUS SYSTEM DISORDER 330 0.0106
930 CONJUNCTIVITIS 196 0.0106
931 RASH MACULO-PAPULAR 233 0.0105
932 DEVICE ISSUE 933 0.0104
933 INCORRECT PRODUCT ADMINISTRATION DURATION 225 0.0104
934 NEEDLE ISSUE 302 0.0104
935 PRODUCT ADMINISTRATION ERROR 209 0.0103
936 DRUG ERUPTION 182 0.0103
937 MALIGNANT NEOPLASM PROGRESSION 1048 0.0102
938 PNEUMONITIS 277 0.0102
939 NEUTROPHIL COUNT DECREASED 410 0.0100
940 INJECTION SITE REACTION 684 0.0099
941 EXTRA DOSE ADMINISTERED 401 0.0099
942 DEVICE DELIVERY SYSTEM ISSUE 271 0.0099
943 TRANSAMINASES INCREASED 220 0.0099
944 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2000 0.0099
945 SEDATION 257 0.0098
946 DEATH 8448 0.0098
947 LEUKOPENIA 490 0.0098
948 SUICIDE ATTEMPT 593 0.0098
949 INJECTION SITE SWELLING 749 0.0098
950 COMA 465 0.0098
951 OSTEONECROSIS 320 0.0097
952 HEPATITIS 249 0.0097
953 LUNG NEOPLASM MALIGNANT 395 0.0096
954 ANAPHYLACTIC SHOCK 247 0.0096
955 SKIN BURNING SENSATION 683 0.0095
956 MULTIPLE ORGAN DYSFUNCTION SYNDROME 269 0.0095
957 VAGINAL HAEMORRHAGE 412 0.0095
958 MUCOSAL INFLAMMATION 246 0.0094
959 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1686 0.0093
960 INJECTION SITE URTICARIA 229 0.0093
961 NEOPLASM MALIGNANT 611 0.0091
962 THERAPEUTIC RESPONSE SHORTENED 302 0.0091
963 PRODUCT PRESCRIBING ERROR 213 0.0089
964 ECZEMA 459 0.0088
965 DERMATITIS ATOPIC 461 0.0087
966 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 294 0.0087
967 INJECTION SITE WARMTH 179 0.0087
968 INCORRECT DOSE ADMINISTERED BY DEVICE 223 0.0085
969 FEBRILE NEUTROPENIA 549 0.0083
970 PANCREATIC CARCINOMA 235 0.0081
971 BREAST CANCER FEMALE 214 0.0080
972 DRUG WITHDRAWAL SYNDROME 697 0.0079
973 NEUTROPENIA 1072 0.0079
974 OVERDOSE 1684 0.0078
975 GAMMA-GLUTAMYLTRANSFERASE INCREASED 171 0.0077
976 DEVICE LEAKAGE 334 0.0077
977 SKIN IRRITATION 332 0.0072
978 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 335 0.0072
979 ACNE 518 0.0068
980 INCORRECT ROUTE OF DRUG ADMINISTRATION 231 0.0065
981 PROSTATE CANCER 506 0.0063
982 INTERSTITIAL LUNG DISEASE 293 0.0060
983 BREAST CANCER 519 0.0056
984 ACCIDENTAL EXPOSURE TO PRODUCT 502 0.0049
985 DRUG DOSE OMISSION BY DEVICE 370 0.0047
986 DEVICE BREAKAGE 190 0.0047
987 DEVICE DISLOCATION 199 0.0046
988 BLADDER CANCER 253 0.0043
989 PRODUCT STORAGE ERROR 338 0.0039
990 RENAL CANCER 174 0.0036
991 DRUG ABUSE 259 0.0031
992 FOETAL EXPOSURE DURING PREGNANCY 241 0.0030
993 DRUG DEPENDENCE 470 0.0029